The WACC of Fate Therapeutics Inc (FATE) is 6.1%.
| Range | Selected | |
| Cost of equity | 6.70% - 10.30% | 8.50% |
| Tax rate | 26.20% - 27.00% | 26.60% |
| Cost of debt | 5.00% - 5.00% | 5.00% |
| WACC | 5.2% - 7.0% | 6.1% |
| Category | Low | High |
| Long-term bond rate | 3.9% | 4.4% |
| Equity market risk premium | 4.6% | 5.6% |
| Adjusted beta | 0.61 | 0.97 |
| Additional risk adjustments | 0.0% | 0.5% |
| Cost of equity | 6.70% | 10.30% |
| Tax rate | 26.20% | 27.00% |
| Debt/Equity ratio | 1 | 1 |
| Cost of debt | 5.00% | 5.00% |
| After-tax WACC | 5.2% | 7.0% |
| Selected WACC | 6.1% | |